Hedgehog signaling is activated in CML LSCs by upregulation of Smo persisting despite TKI-therapy suggesting this pathway is BCRABL1-independent [71]. The gene discussed is SMO; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.